ASX - By Stock
|
IDT |
Re:
Ann: IDT Onshore mRNA Manufacturing ATM Outcome & StrategyUpdate
|
|
mountfranklin
|
64 |
23K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
64
|
23K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Sterile License Approval and Manufacture
|
|
mountfranklin
|
65 |
16K |
1 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
65
|
16K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Response to ASX Query
|
|
mountfranklin
|
62 |
11K |
2 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
62
|
11K
|
2
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Change in substantial holding from SNC
|
|
mountfranklin
|
5 |
2.3K |
1 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
5
|
2.3K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Government looking for mRNA producers - IDT
|
|
mountfranklin
|
12 |
3.8K |
1 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
12
|
3.8K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Investor Survey: The Future of alternative medicines and the impact on cannabis stocks
|
|
mountfranklin
|
9 |
4.7K |
0 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
9
|
4.7K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Investor Survey: The Future of alternative medicines and the impact on cannabis stocks
|
|
mountfranklin
|
9 |
4.7K |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
9
|
4.7K
|
4
|
|
ASX - By Stock
|
IDT |
Re:
Ann: IDT Australia Anti-Bribery and Corruption Policy
|
|
mountfranklin
|
53 |
12K |
3 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
53
|
12K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: IDT Australia Anti-Bribery and Corruption Policy
|
|
mountfranklin
|
53 |
12K |
8 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
53
|
12K
|
8
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 22
|
|
mountfranklin
|
240 |
39K |
1 |
22/04/21 |
22/04/21 |
ASX - Day Trading
|
240
|
39K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 22
|
|
mountfranklin
|
240 |
39K |
1 |
22/04/21 |
22/04/21 |
ASX - Day Trading
|
240
|
39K
|
1
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 22
|
|
mountfranklin
|
240 |
39K |
2 |
22/04/21 |
22/04/21 |
ASX - Day Trading
|
240
|
39K
|
2
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 22
|
|
mountfranklin
|
240 |
39K |
0 |
22/04/21 |
22/04/21 |
ASX - Day Trading
|
240
|
39K
|
0
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 21
|
|
mountfranklin
|
311 |
51K |
0 |
21/04/21 |
21/04/21 |
ASX - Day Trading
|
311
|
51K
|
0
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 21
|
|
mountfranklin
|
328 |
50K |
0 |
21/04/21 |
21/04/21 |
ASX - Day Trading
|
328
|
50K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
ARPC: 3 -12 months to mRNA vaccine productions!
|
|
mountfranklin
|
14 |
4.1K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
14
|
4.1K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Ceasing to be a substantial holder
|
|
mountfranklin
|
8 |
2.6K |
0 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 16
|
|
mountfranklin
|
426 |
59K |
0 |
16/04/21 |
16/04/21 |
ASX - Day Trading
|
426
|
59K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Becoming a substantial holder
|
|
mountfranklin
|
17 |
3.5K |
4 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
17
|
3.5K
|
4
|
|
ASX - By Stock
|
IDT |
Re:
chart
|
|
mountfranklin
|
131 |
25K |
1 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
131
|
25K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
2 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
930
|
200K
|
2
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 14
|
|
mountfranklin
|
298 |
49K |
0 |
14/04/21 |
14/04/21 |
ASX - Day Trading
|
298
|
49K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
3 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
930
|
200K
|
3
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 14
|
|
mountfranklin
|
401 |
59K |
1 |
14/04/21 |
14/04/21 |
ASX - Day Trading
|
401
|
59K
|
1
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 14
|
|
mountfranklin
|
401 |
59K |
3 |
14/04/21 |
14/04/21 |
ASX - Day Trading
|
401
|
59K
|
3
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 14
|
|
mountfranklin
|
401 |
59K |
0 |
14/04/21 |
14/04/21 |
ASX - Day Trading
|
401
|
59K
|
0
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 14
|
|
mountfranklin
|
401 |
59K |
0 |
14/04/21 |
14/04/21 |
ASX - Day Trading
|
401
|
59K
|
0
|
|
ASX - Day Trading
|
|
Re:
Morning trading April 14
|
|
mountfranklin
|
401 |
59K |
1 |
14/04/21 |
14/04/21 |
ASX - Day Trading
|
401
|
59K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
3 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
930
|
200K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
I'm not selling
|
|
mountfranklin
|
28 |
5.1K |
6 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
28
|
5.1K
|
6
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
3 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
930
|
200K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
3 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
930
|
200K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
3 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
930
|
200K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
930
|
200K
|
2
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
0 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
930
|
200K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
0 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
930
|
200K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
0 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
930
|
200K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Ceasing to be a substantial holder
|
|
mountfranklin
|
38 |
6.4K |
1 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
38
|
6.4K
|
1
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 7
|
|
mountfranklin
|
234 |
39K |
2 |
07/04/21 |
07/04/21 |
ASX - Day Trading
|
234
|
39K
|
2
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
0 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
930
|
200K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
9 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
930
|
200K
|
9
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
5 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
930
|
200K
|
5
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 6
|
|
mountfranklin
|
376 |
60K |
0 |
06/04/21 |
06/04/21 |
ASX - Day Trading
|
376
|
60K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
mountfranklin
|
930 |
200K |
1 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
930
|
200K
|
1
|
|